RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Reno, NV · +55 more sites
Obesity clinical trials in Reno, NV
3 recruiting obesity studies with a site in Reno, NV.
RecruitingPhase 3NCT07794579
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Sponsor: Eli Lilly and Company
Las Vegas, NV · Reno, NV · +78 more sites
RecruitingPhase 4NCT06857942
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Sponsor: Eli Lilly and Company
Reno, NV · +38 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.